• Something wrong with this record ?

Preservation of urine specimens for metabolic evaluation of recurrent urinary stone formers

T. Šálek, P. Musil, P. Vermeersch, R. Marrington, ZG. Dikmen, R. Poláchová, U. Kipman, TT. Kouri, J. Cadamuro, Working Group Preanalytical Phase (WG-PRE) and Task and Finish Group Urinalysis (TFG-U), European Federation of Clinical Chemistry and...

. 2025 ; 63 (1) : 129-138. [pub] 20240730

Language English Country Germany

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25002835

OBJECTIVES: Stability of concentrations of urinary stone-related metabolites was analyzed from samples of recurrent urinary stone formers to assess necessity and effectiveness of urine acidification during collection and storage. METHODS: First-morning urine was collected from 20 adult calcium-stone forming patients at Tomas Bata Hospital in the Czech Republic. Urine samples were analyzed for calcium, magnesium, inorganic phosphate, uric acid, sodium, potassium, chloride, citrate, oxalate, and urine particles. The single-voided specimens were collected without acidification, after which they were divided into three groups for storage: samples without acidification ("NON"), acidification before storage ("PRE"), or acidification after storage ("POST"). The analyses were conducted on the day of arrival (day 0, "baseline"), or after storage for 2 or 7 days at room temperature. The maximum permissible difference (MPD) was defined as ±20 % from the baseline. RESULTS: The urine concentrations of all stone-related metabolites remained within the 20 % MPD limits in NON and POST samples after 2 days, except for calcium in NON sample of one patient, and oxalate of three patients and citrate of one patient in POST samples. In PRE samples, stability failed in urine samples for oxalate of three patients, and for uric acid of four patients after 2 days. Failures in stability often correlated with high baseline concentrations of those metabolites in urine. CONCLUSIONS: Detailed procedures are needed to collect urine specimens for analysis of urinary stone-related metabolites, considering both patient safety and stability of those metabolites. We recommend specific preservation steps.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25002835
003      
CZ-PrNML
005      
20250206103909.0
007      
ta
008      
250121s2025 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1515/cclm-2024-0773 $2 doi
035    __
$a (PubMed)39072394
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Šálek, Tomáš $u Department of Clinical Biochemistry and Pharmacology, 37742 Tomas Bata Hospital Zlín , Zlín, Czech Republic $u Institute of Clinical Biochemistry and Diagnostics, Medical Faculty in Hradec Králové, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000283925003 $7 xx0174625
245    10
$a Preservation of urine specimens for metabolic evaluation of recurrent urinary stone formers / $c T. Šálek, P. Musil, P. Vermeersch, R. Marrington, ZG. Dikmen, R. Poláchová, U. Kipman, TT. Kouri, J. Cadamuro, Working Group Preanalytical Phase (WG-PRE) and Task and Finish Group Urinalysis (TFG-U), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
520    9_
$a OBJECTIVES: Stability of concentrations of urinary stone-related metabolites was analyzed from samples of recurrent urinary stone formers to assess necessity and effectiveness of urine acidification during collection and storage. METHODS: First-morning urine was collected from 20 adult calcium-stone forming patients at Tomas Bata Hospital in the Czech Republic. Urine samples were analyzed for calcium, magnesium, inorganic phosphate, uric acid, sodium, potassium, chloride, citrate, oxalate, and urine particles. The single-voided specimens were collected without acidification, after which they were divided into three groups for storage: samples without acidification ("NON"), acidification before storage ("PRE"), or acidification after storage ("POST"). The analyses were conducted on the day of arrival (day 0, "baseline"), or after storage for 2 or 7 days at room temperature. The maximum permissible difference (MPD) was defined as ±20 % from the baseline. RESULTS: The urine concentrations of all stone-related metabolites remained within the 20 % MPD limits in NON and POST samples after 2 days, except for calcium in NON sample of one patient, and oxalate of three patients and citrate of one patient in POST samples. In PRE samples, stability failed in urine samples for oxalate of three patients, and for uric acid of four patients after 2 days. Failures in stability often correlated with high baseline concentrations of those metabolites in urine. CONCLUSIONS: Detailed procedures are needed to collect urine specimens for analysis of urinary stone-related metabolites, considering both patient safety and stability of those metabolites. We recommend specific preservation steps.
650    _2
$a lidé $7 D006801
650    12
$a močové kameny $x moč $7 D014545
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a recidiva $7 D012008
650    _2
$a odběr biologického vzorku $x metody $7 D013048
650    _2
$a kyselina močová $x moč $7 D014527
650    _2
$a analýza moči $x metody $7 D016482
650    _2
$a sbírání vzorku moči $x metody $7 D059349
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Musil, Pavel $u Department of Clinical Biochemistry and Pharmacology, 37742 Tomas Bata Hospital Zlín , Zlín, Czech Republic
700    1_
$a Vermeersch, Pieter $u Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium $1 https://orcid.org/000000017076061X
700    1_
$a Marrington, Rachel $u Birmingham Quality (UK NEQAS), University Hospitals NHS Foundation Trust, Birmingham, UK
700    1_
$a Dikmen, Zeliha G $u Clinical Pathology Laboratory, Department of Medical Biochemistry and Hacettepe University Hospitals, Hacettepe University Faculty of Medicine, Ankara, Türkiye
700    1_
$a Poláchová, Radka $u Department of Clinical Biochemistry and Pharmacology, 37742 Tomas Bata Hospital Zlín , Zlín, Czech Republic
700    1_
$a Kipman, Ulrike $u College of Education, Salzburg, Austria $1 https://orcid.org/0000000310458456
700    1_
$a Kouri, Timo T $u Department of Clinical Chemistry, University of Helsinki, Espoo, Finland $u Hospital District of Helsinki and Uusimaa, HUS Diagnostic Center, HUSLAB, Helsinki, Finland $1 https://orcid.org/000000023282232X
700    1_
$a Cadamuro, Janne $u Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria $1 https://orcid.org/0000000262009831
710    2_
$a Working Group Preanalytical Phase (WG-PRE) and Task and Finish Group Urinalysis (TFG-U), European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
773    0_
$w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 63, č. 1 (2025), s. 129-138
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39072394 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206103905 $b ABA008
999    __
$a ok $b bmc $g 2262936 $s 1238842
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 63 $c 1 $d 129-138 $e 20240730 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Archiving options